Search research articles
Contact Us
Filters
Showing results (1-10 of 323) with videos related to
Page
of 33
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
February 2, 2021
Further evidence that MRI based measurement of midbrain neuromelanin may serve as a proxy measure of brain dopamine activity in psychiatric disorders
Cameron S Carter
Schizophrenia Bulletin
|
August 19, 2005
Applying new approaches from cognitive neuroscience to enhance drug development for the treatment of impaired cognition in schizophrenia
Cameron S Carter
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
|
February 5, 2018
Clusters, Dimensions, and Hierarchies: Finding a Path Forward for the Neuroscience of Mental Disorders?
Cameron S Carter
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
|
March 22, 2018
As the Field Matures … We Begin
Cameron S Carter
Biological Psychiatry
|
February 10, 2009
The ups and downs of emotion regulation
Cameron S Carter
Proceedings of the National Academy of Sciences of the United States of America
|
July 10, 2015
Rectifying disordered brain dynamics to improve cognition in schizophrenia
Cameron S Carter
Biological Psychiatry
|
September 15, 2007
Some rewarding insights into the cognitive and neurobiological basis of negative symptoms in schizophrenia
Cameron S Carter
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
|
January 11, 2020
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging Spreads Its Wings
Cameron S Carter
Biological Psychiatry
|
June 26, 2012
Neuroeconomics: sharpened tools of value for clinical cognitive and affective neuroscience
Cameron S Carter
The American Journal of Psychiatry
|
March 4, 2006
Understanding the glass ceiling for functional outcome in schizophrenia
Cameron S Carter
Page
of 33
Search research articles
Search
Showing results (1-10 of 323) with videos related to
Sort By:
Page
of 33
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
February 2, 2021
Further evidence that MRI based measurement of midbrain neuromelanin may serve as a proxy measure of brain dopamine activity in psychiatric disorders
Cameron S Carter
Schizophrenia Bulletin
|
August 19, 2005
Applying new approaches from cognitive neuroscience to enhance drug development for the treatment of impaired cognition in schizophrenia
Cameron S Carter
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
|
February 5, 2018
Clusters, Dimensions, and Hierarchies: Finding a Path Forward for the Neuroscience of Mental Disorders?
Cameron S Carter
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
|
March 22, 2018
As the Field Matures … We Begin
Cameron S Carter
Biological Psychiatry
|
February 10, 2009
The ups and downs of emotion regulation
Cameron S Carter
Proceedings of the National Academy of Sciences of the United States of America
|
July 10, 2015
Rectifying disordered brain dynamics to improve cognition in schizophrenia
Cameron S Carter
Biological Psychiatry
|
September 15, 2007
Some rewarding insights into the cognitive and neurobiological basis of negative symptoms in schizophrenia
Cameron S Carter
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
|
January 11, 2020
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging Spreads Its Wings
Cameron S Carter
Biological Psychiatry
|
June 26, 2012
Neuroeconomics: sharpened tools of value for clinical cognitive and affective neuroscience
Cameron S Carter
The American Journal of Psychiatry
|
March 4, 2006
Understanding the glass ceiling for functional outcome in schizophrenia
Cameron S Carter
Page
of 33